Sekar Kathiresan, Verve Therapeutics CEO

Verve gets New Zealand clear­ance to test base edit­ing ther­a­py di­rect­ly in the hu­man body

Two years ago, In­tel­lia and Ed­i­tas Med­i­cine ven­tured in­to the field of sci­ence fic­tion when the biotechs di­rect­ly edit­ed genes in hu­mans.

Now, fol­low­ing be­hind …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.